Obesity paradox does exist

Diabetes Care

Volumn 36, Issue SUPPL.2, 2013, Pages

  Hainer, Vojtech ^a   Aldhoon Hainerová, Irena ^a,b  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR; THROMBOXANE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY COMPOSITION; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; FATTY ACID SYNTHESIS; FITNESS; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LOW RISK POPULATION; MUSCLE MASS; MUSCLE STRENGTH; NUTRITIONAL STATUS; OBESITY; OBESITY PARADOX; SENSITIVITY ANALYSIS;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; CORONARY DISEASE; HEART FAILURE; HUMANS; NUTRITIONAL STATUS; OBESITY; OVERWEIGHT; PHYSICAL FITNESS;

EID: 84891823354     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dcS13-2023     Document Type: Article

References (63)

1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861-1867
2. Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39:578-584
3. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006;368:666-678
4. Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007;120:863-870
5. Younge JO, Damen NL, van Domburg RT, Pedersen SS. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: In search of an explanation for the obesity paradox. Int J Cardiol. 2 April 2012 [Epub ahead of print]
6. Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010;31:222-226
7. Buchholz EM, Rathore SS, Reid KJ, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med 2012;125:796-803
8. Kovacic JC, Lee P, Baber U, et al. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis 2012;221:176-182
9. Persy V, D'Haese P. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 2009;15:405-416
10. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439-1444
11. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61
12. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108, 927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007; 153:74-81
13. Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011;58:1343-1350
14. Zapatero A, Barba R, Gonzalez N, et al. Influence of obesity and malnutrition on acute heart failure. Rev Esp Cardiol (Engl Ed) 2012;65:421-426
15. Komukai K, Minai K, Arase S, et al. Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J 2012;76:145-151
16. Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012; 110:77-82
17. Zamora E, Lupón J, de Antonio M, et al. The obesity paradox in heart failure: Is etiology a key factor? Int J Cardiol 2013; 166:601-605
18. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012;3:1-4
19. Galal W, van Gestel YR, Hoeks SE, et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008;134: 925-930
20. Barba R, Bisbe J, Pedrajas JN, et al.; FRENA Investigators. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009; 16: 457-463
21. Vemmos K, Ntaios G, Spengos K, et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011;42:30-36
22. Jackson RS, Black JH 3rd, Lum YW, et al. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy. J Vasc Surg 2012;55:1306-1312
23. Barba R, Zapatero A, Losa JE, et al.; Riete Investigators. Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 2008; 6:595-600
24. Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox. Thromb Res 2011;128:518-523
25. Potapov EV, Loebe M, Anker S, et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 2003;24:1933-1941
26. Aldhoon B, Wichterle D, Peichl P, Cihak R, Kautzner J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 2013; 15: 24-32
27. Hutagalung R, Marques J, Kobylka K, et al. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 2011;37:1793-1799
28. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009;250:166-172
29. Doehner W, Erdmann E, Cairns R, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 2012;162:20-26
30. Sohn M-W, Budiman-Mak E, Oh EH, et al. Obesity paradox in amputation risk among nonelderly diabetic men. Obesity (Silver Spring) 2012;20:460-462
31. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856-1861
32. Blum A, Simsolo C, Sirchan R, Haiek S. "Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J 2011; 13:672-675
33. Lainscak M, von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011;2:81-86
34. Kalantar-Zadeh K, Streja E, Molnar MZ, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012;175:793-803
35. Martino JL, Stapleton RD, Wang M, et al. Extreme obesity and outcomes in critically ill patients. Chest 2011;140:1198-1206
36. Chang CS, Chang YF, Wang MW, et al. Inverse Relationship Between Central Obesity and Osteoporosis in Osteoporotic Drug Naive Elderly Females: The Tianliao Old People (TOP) Study. J Clin Densitom 2013;16:204-211
37. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359:2105-2120
38. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-215
39. Mathus-Vliegen EMH, Basdevant A, Finer N, et al.; Obesity Management Task Force of the European Association for the Study of Obesity. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts 2012;5:460-483
40. Lee CG, Fujimoto WY, Brunzell JD, et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese-American adults. Diabetes Res Clin Pract 2010;89:58-64
41. Hairston KG, Scherzinger A, Foy C, et al. Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes Care 2009;32: 1553-1555
42. Snijder MB, Dekker JM, Visser M, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003; 77:1192-1197
43. Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R. Association of waist and hip circumference with 12-year progression of carotid in-tima-media thickness in elderly women. Int J Obes (Lond) 2007;31:1406-1411
44. Debette S, Leone N, Courbon D, et al. Calf circumference is inversely associated with carotid plaques. Stroke 2008;39:2958-2965
45. Heymsfield SB, Martin-Nguyen A, Fong TM, Gallagher D, Pietrobelli A. Body circumferences: clinical implications emerging from a new geometric model. Nutr Metab (Lond) 2008;5:24
46. Schenkeveld L, Magro M, Oemrawsingh RM, et al. The influence of optimal medical treatment on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open 2012;2:e000535
47. Oreopoulos A, Ezekowitz JA, McAlister FA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010;85:609-617
48. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Nutr Metab Care 2008;11:693-700
49. Casas-Vara A, Santolaria F, Fernandez-Bereciartúa A, Gonzalez-Reimers E, Garcia-Ochoa A, Martfnez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 2012;28:616-622
50. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007;86:1339-1346
51. Hainer V, Toplak H, Stich V. Fat or fit: what is more important? Diabetes Care 2009;32(Suppl 2):S392-S397
52. McAuley PA, Artero EG, Sui X, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012;87:443-451
53. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61:72-77
54. Izawa KP, Watanabe S, Osada N, et al. Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure. Eur J Cardiovasc Prev Rehabil 2009;16:21-27
55. Kortelainen ML, Porvari K. Extreme obesity and associated cardiovascular disease verified at autopsy: time trends over 3 decades. Am J Forensic Med Pathol 2011; 32:372-377
56. Biasucci LM, Graziani F, Rizzello V, et al. Paradoxical preservation of vascular function in severe obesity. Am J Med 2010;123: 727-734
57. Fadini GP, Boscaro E, de Kreutzenberg S, et al. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 2010;33:1097-1102
58. Graziani F, Biasucci LM, Cialdella P, et al. Thromboxane production in morbidly obese subjects. Am J Cardiol 2011;107: 1656-1661
59. Ledderose C, Kreth S, Beiras-Fernandez A. Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function. Recent Pat Endocr Metab Immune Drug Discov 2011;5:1-6
60. Rodriguez A, Gómez-Ambrosi J, Catalan V, et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 2010;28:560-567
61. Lund LH, Williams JJ, Freda P, LaManca JJ, Le Jemtel TH, Mancini DM. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail 2009;11:789-794
62. Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000;35:537-544
63. Heymsfield SB, Cefalu WT. Does body mass index adequately convey a patient's mortality risk? JAMA 2013;309:87-88